Best Agrolife Ltd. · NSE:BESTAGRO
Best Agrolife — Q1 FY2024 Earnings Presentation
18 slides from Best Agrolife's earnings presentation, July 2023
Slide 1: Regulation 30 intimation cover letter to BSE
Best A$ro tiieLimited #- CIN : L74l I ODLI 992pLC1 1 6773 tlstluly,2023 The Manager Compliance Department I}SE l,td Phiroze f eejeebhoy Towers, Dalal Street, Mumbai-400001 SCRIP CODE: 539660 SCRIP ID: BESTAGRO Sublect; Intimation under Regulation 30 Corporate Presentation Dear Sir/Madam, Pursuant to
Slide 2: Q1FY24 Earnings Presentation
Q1FY24 Earnings Presentation Best Agrolife Limited 1
Slide 3: Disclaimer
Disclaimer The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation that any i
Slide 4: Q1FY24 Highlights
Q1FY24 Highlights “I am delighted to share that Best Agrolife has achieved remarkable growth momentum, with revenue from operations growing by 32% Y-o-Y to Rs 612Cr, despite the headwinds that the agrochemicals industry has been facing. Our branded products including Ronfen, Citigen & Vistara (CTPR)
Slide 5: Financial Highlights
Financial Highlights Financial Highlights: Q1FY24 Revenue from operations for Q1FY24 stood at Rs. 612 cr which grew by 141% QoQ and 32% on YoY basis compared to Rs. 254 cr in Q4FY23 and Rs. 464 cr in Q1FY23 Gross margin for the quarter is at 30% as compared to 19% in Q4FY23 and 21% in Q1FY23 whi
Slide 6: Key Business Highlights
Key Business Highlights Key Business Highlights: Product Launch in Q1FY24 BAL Launched 2 herbicide products during the quarter, Propiquazafop and Ametryn under the brand name Propique and Amito respectively Harnessing Clean Energy Best Crop Science, (a subsidiary of BAL) has entered a PPA and SH
Slide 7: Key Business Highlights
Key Business Highlights Key Business Highlights: Approvals and Registrations received BAL is the First Indian Agrochemical Manufacturer that has been granted registration for indigenous manufacturing of the product Trifloxystrobin 10% + Difenoconazole 12.5% + Sulphur 3% Sc under section 9 (3) FIM.
Slide 8: Strong revenue growth coupled with improving margins
Strong revenue growth coupled with improving margins Revenue EBITDA PAT Q1FY24 90 464 700 328 254 612 66 183 58 7 130 40 130 31 Q1 Q2 Q3 -8 Q4 Q1 Q1 Q2 Q3 Q4 Q1 Q1 Q2 Q3 Q4 Q1 FY23 FY23 FY23 FY23 FY24 FY23 FY23 FY23 FY23 FY24 FY23 FY23 FY23 FY23 FY24 7
Slide 9: Products Launched
Products Launched TOMBO A new generation corn herbicide Tembotrione shows a fast efficacy in control of weeds. A first of its kind ternary insecticidal combination of Best It is altd, Agrolife post emergence Ronfen is a singleherbicide that shot solution dissipates that controls allrapidly sucki
Slide 10: Products Launched
Products Launched CITIGEN (CTPR) It is a Aplant first of its kind ternary systemic insecticidal insecticide combination that belongs of Best to the group anthranilic diamide, which has a unique mode of action first to launch Agrolife ltd, Ronfen is a single shot solution that controls all sucking
Slide 11: Product Launch Plan FY24
Product Launch Plan FY24 HERBICIDE Product Patent HALOXYFOP + Patent for herbicidal Composition of Haloxyfop + Imazethapyr + chlorimuron Received IMAZETHAPYR + A very prominent one-shot solution for an important crop like Soyabean. High importance not only in India but in other CHLORIMURON soybe
Slide 12: Product Launch Plan FY24
Product Launch Plan FY24 FUNGICIDE Product Patent DIFENOCONAZOLE + Received TRIFLOXYSTROBIN + Broad spectrum fungicide 3X formulae where sulphur acts as a catalyst Composition of Difenoconazole, Trifloxystrobin and sulphur SULPHUR TO BE LAUNCHED We plan to launch this combination PAN India wit
Slide 13: P&L For Q1FY24
P&L For Q1FY24 Value (INR Cr) Q1 FY24 Q1 FY23 YoY (%) Q4 FY23 QoQ (%) Revenue from Operation 612 464 32% 254 141% Other Income 4 0 1 Total Revenue 617 464 33% 255 142% Cost of Goods Sold 429 365 17% 206 109% Employee Benefits Expense 16 9 83% 14 13% Other Operating Expenses 37 24 56% 27 38% Total Ex
Slide 14: Improving Return Ratios and Stable balance sheet
Improving Return Ratios and Stable balance sheet ROCE ROE 50% 36% 33% 32% 39% 24% FY21 FY22 FY23 FY21 FY22 FY23 Net Debt to Equity Current Ratio 1.38 0.91 0.82 0.70 1.36 1.35 FY21 FY22 FY23 FY21 FY22 FY23 13
Slide 15: Experienced Management with Domain Knowledge
Experienced Management with Domain Knowledge Management with a cumulative experience of more than five decades Mr. Vimal Kumar Mr. S. B. V. Rama Prasad Mr. P . N. Karlerkar Mr. N Surendra Sai Mr. Sanjeev Kharbanda MANAGING DIRECTOR MANAGING DIRECTOR EXECUTIVE DIRECTOR ( Best Crop Science Pvt Ltd ) H
Slide 16: Outlook
Outlook Revenue Growth : 32% EBITDA Margin of 21% 1 2 3 4 Launch of new Ramping up Maximizing Expanding & innovative distribution & backward Market products with branded integration to Footprint – higher margins products business improve Domestic & efficiencies Overseas 15
Slide 17: Share Information
Share Information Shareholding as on 30th June 2023 Share Information (as on 30th June 2023) BSE Ticker 539660 Market Cap (INR Cr) 2,722.46 Others % free-float 49.9% 36.5% Free-float market cap (INR Cr) 1,358.43 Total Debt (INR Mn) 561.74 Promoters Cash & Cash Equivalents (INR Mn)# 63.4 50.1% Shares
Slide 18: For queries please contact
For queries please contact: EY IR PRACTICE Rahul Thakur rahul.thakur@in.ey.com Vikash Verma vikash.verma1@in.ey.com DISCLAIMER This presentation includes certain forward looking statements and information including statements concerning the outlook for business. The statements are based on certain e